Does High Testosterone Cause Prostate Cancer?

Does High Testosterone Cause Prostate Cancer?

image

It’s increasingly common for patients to be told by their medical doctors that testosterone is “bad” for the prostrate. They often also advise patients that testosterone makes prostate cancer grow. Although treatment in many prostate cancer patients is specifically designed to reduce testosterone levels, there are many studies available that show that the fall in testosterone in men actually almost parallels the rise in BPH, prostatitis and prostate cancer, which throws up some pretty interesting questions.

Here, we provide a breakdown of just a few of the studies around testosterone and the prostate, and the conclusions reached, in the hope that many of you will begin to take charge of any prostate conditions, and realise that not only are the major players in the treatment of prostate issues the pharmaceutical companies, but that you can use the information provided here to make better decisions about the care of your prostate.

The Imperial Cancer Research Fund – 1971

This study, held in London studied hormone levels of 49 men. The study reported that health men had testosterone levels that were much higher than those with advanced metastatic cancer, and higher than those with prostate cancer. Let that sink in for a moment – and bear in mind that this was over 40 years ago.

The Granada Medical Facility – 1978

The Granada Medical Facility’s 1978 study of 18 men with BPH, who were studied and compared with healthy males of the same age group, discovered that those with BPH has an average level of testosterone that was 2.3ng/ml – 43% lower than the average 4.0 ng/ml. A direct quote taken from their findings, which were published in a major medical journal stated clearly “the testosterone concentration in the BPH group was significantly lower than that of the healthy control group. In addition to this confirmation, consider that the authors of this study already knew that estradiol levels in men rise as they age, and supplementation of estradiol causes abnormal growth in the prostate gland.

University of Witwaterstrand – 1997

This 1997 study in Africa was entitled “Low Serum Testosterone Predicts a Poor Outcome in Metastatic Prostate Cancer.”  122 patients were studied, and the results showed that those with the highest levels of testosterone had tumors that were the least aggressive – and in addition to this, they lived the longest. The patients included in the study with the lowest testosterone levels saw far more aggressive growth in their prostate cancers, and died much earlier. The conclusion – “Low testosterone seems to result in a more aggressive disease and a poorer prognosis in advanced prostate cancer.” – could not be clearer.

Hubei Medical University  – 1998

A study by three doctors in China of men with BPH and carcinoma (PCA) found that patients with BPH and PCA presented with lower serum testosterone than the healthy control group.  In addition to this, was more confirmation of the involvement on estradiol, and the study reported, “The ratio of testosterone-to-estradiol is decreased with the rise of the age. The results suggested that the imbalance of serum sex hormones [i.e. falling testosterone and rising estrogen] was related to the pathogenesis of BPH and PCA.” Simply put, this shows their findings that high estrogen and low testosterone levels that cause prostate issues.

University of Washington – 1999 – Richard Prehn

Pioneering doctor Richard Prehn published the suggestion that androgen supplementation should be considered in order reduce the growth of prostate cancer. Pointing out that decreasing levels of testosterone play a role in carcinogenesis, he suggested that supplementing low testosterone levels could cut cancer rates. As part of his suggested treatment option, he referred to earlier studies that had shown worse prognosis in prostate cancer patients with low testosterone.

Notable discoveries and treatment suggestions

Studying The University of Chicago and three other clinics in 1991, it’s clear to see that the evidence is there as to treatments that work. They found that the higher testosterone levels in their study groups were, the longer men lived and the better they fared, and revealed that “These results have important implications for the design and analysis of future clinical trials of hormone therapy.” and “Doctors should be giving men testosterone therapy, rather than “androgen ablation.” This shows that even back in 1991, mainstream treatments, which are for the most part the same as they are in most medical facilities now, were proven wrong and advice showed that Doctors should be treating patients in the opposite way they are doing today.

Why ignore the results of scientific studies?

There are many studies published around the world dating back years that claimed that doctors were aware of the detrimental effect estrogen had on the prostate while also knowing that testosterone had a positive effect on prostate health.  Each month, more and more research is published on testosterone, yet it is largely ignored – so why is this?

One simple theory is that in mainstream medicine, often opinions about a disease, causes and treatment take a long time to change. Sometimes this is found to be down to the conservative nature of the medical profession, which has often been found as resistant to change. Quite often, from new research to general acceptance, change can easily take a generation or more – but surely we should be seeing change now?

One simple theory is that in mainstream medicine, often opinions about a disease, causes and treatment take a long time to change. Sometimes this is found to be down to the conservative nature of the medical profession, which has often been found as resistant to change. Quite often, from new research to general acceptance, change can easily take a generation or more – but surely we should be seeing change now?

Another, perhaps more sinister conclusion is that some professors and senior doctors across the globe have built their reputations based on mistakenly held beliefs that testosterone is the sole cause of prostate issues and are unwilling to admit that their beliefs were mistaken. Perhaps even worse than this, the pharmaceutical giants that produce profitable Testosterone combatant drugs, prefer to disregard this research, that would clearly be detrimental to their bottom line.

Whatever the reason for the lack of change in treatment protocol in the medical field, from the research studies above, isn’t it time you thought long and hard about what prostate treatment protocol is right for you? 

So if you want to reduce your chances of getting Prostate Cancer naturally without any harmful pharmaceutical drugs or surgery then Click Here. 

References

Ong, Ben. All About The Prostate. USA: bensprostate.com, 2016. Print.

  • Jim Trompe

    Dihydrotestosterone is a derivative of Testosterone(as is Estrogen) I’ve seen solid arguments that excessive Dihydro causes baldness(by reducing immunity-this is why antibiotic/antifungals regrow hair) and prostate cancer. This is also why baldness is strongly associated with aggressive prostate cancer. When there is artherosclerosis the bloodflow is restricted and Dihydro builds up to excessive levels in a few places. Artherosclerosis is the true problem even though lowering Dihydro can work. A good reason not to decrease dihydro? Its responsible for the development of the penis, and likely is a large part of the libido(research the guevedoces of the Dominican Republic).